{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:14:10Z","timestamp":1783487650063,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12890-018-0678-5","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T06:13:06Z","timestamp":1534140786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2049-5536","authenticated-orcid":false,"given":"Michael S.","family":"Broder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen P.","family":"Neary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"678_CR1","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.ejca.2012.12.022","volume":"49","author":"CM Korse","year":"2013","unstructured":"Korse CM, Taal BG, van Velthuysen M-LF, Visser O. Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry. Eur J Cancer. 2013;49:1975\u201383.","journal-title":"Eur J Cancer"},{"key":"678_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61\u201372.","journal-title":"Lancet Oncol"},{"key":"678_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CCO.0b013e3282f1c595","volume":"20","author":"BI Gustafsson","year":"2008","unstructured":"Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol. 2008;20:1\u201312.","journal-title":"Curr Opin Oncol"},{"key":"678_CR4","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol"},{"key":"678_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/annonc\/mdv505","volume":"27","author":"E Leoncini","year":"2016","unstructured":"Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016;27:68\u201381.","journal-title":"Ann Oncol"},{"key":"678_CR6","doi-asserted-by":"publisher","first-page":"e62487","DOI":"10.1371\/journal.pone.0062487","volume":"8","author":"H-J Tsai","year":"2013","unstructured":"Tsai H-J, Wu C-C, Tsai C-R, Lin S-F, Chen L-T, Chang JS. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PLoS One. 2013;8:e62487. Gorlova OY, editor","journal-title":"PLoS One"},{"key":"678_CR7","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1530\/ERC-13-0125","volume":"21","author":"M Fraenkel","year":"2014","unstructured":"Fraenkel M, Kim M, Faggiano A, de Herder WW, Valk GD. On behalf of the knowledge NETwork. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer. 2014;21:R153\u201363.","journal-title":"Endocr Relat Cancer"},{"key":"678_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","volume":"50","author":"T Ito","year":"2015","unstructured":"Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Takano K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015;50:58\u201364.","journal-title":"J Gastroenterol"},{"key":"678_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cncr.29099","volume":"121","author":"J Hallet","year":"2015","unstructured":"Hallet J, Law CHL, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121:589\u201397.","journal-title":"Cancer"},{"key":"678_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335.","journal-title":"JAMA Oncol"},{"key":"678_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","volume":"39","author":"JP Boudreaux","year":"2010","unstructured":"Boudreaux JP, Klimstra DS, Hassan MM, Woltering EA, Jensen RT, Goldsmith SJ, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and Cecum. Pancreas. 2010;39:753\u201366.","journal-title":"Pancreas"},{"key":"678_CR12","volume-title":"U.S. Census Bureau current population reports. U.S. government printing office","author":"JC Smith","year":"2015","unstructured":"Smith JC, Medalia C. Health insurance coverage in the United States: 2014. In: U.S. Census Bureau current population reports. U.S. government printing office; 2015. \n                    https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2015\/demo\/p60-253.pdf\n                    \n                  . Accessed 24 Jan 2017."},{"key":"678_CR13","volume-title":"Applied regression analysis and other multivariable methods","author":"DG Kleinbaum","year":"1987","unstructured":"Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: Duxbury Press; 1987.","edition":"2"},{"key":"678_CR14","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med. 2009;28:3670\u201382.","journal-title":"Stat Med"},{"key":"678_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/ijc.23529","volume":"123","author":"MM Hassan","year":"2008","unstructured":"Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer. 2008;123:867\u201373.","journal-title":"Int J Cancer"},{"key":"678_CR16","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1001\/jama.2012.5960","volume":"307","author":"R Smith-Bindman","year":"2012","unstructured":"Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012;307:2400\u20139.","journal-title":"JAMA"},{"key":"678_CR17","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1097\/RTI.0000000000000172","volume":"30","author":"JM Eberth","year":"2015","unstructured":"Eberth JM, Sercy E. Implementation of lung Cancer screening in the United States: changing trends based on a survey of Society of Thoracic Radiology Members. J Thorac Imaging. 2015;30:W60\u20132.","journal-title":"J Thorac Imaging"},{"key":"678_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8","volume":"86","author":"E Bajetta","year":"1999","unstructured":"Bajetta E, Ferrari L, Martinetti A, Celio L, Procopio G, Artale S, et al. Chromogranin a, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer. 1999;86:858\u201365.","journal-title":"Cancer"},{"key":"678_CR19","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934\u201359.","journal-title":"Cancer"},{"key":"678_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1572-0241.2003.04027.x","volume":"99","author":"IM Modlin","year":"2004","unstructured":"Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol. 2004;99:23\u201332.","journal-title":"Am J Gastroenterol"},{"key":"678_CR21","volume-title":"Pancreatic neuroendocrine tumors: a population-based analysis of epidemiology and outcomes","author":"S Alsidawi","year":"2017","unstructured":"Alsidawi S, Westin G, Hobday T, Halfdanarson T. Pancreatic neuroendocrine tumors: a population-based analysis of epidemiology and outcomes. 2017."},{"key":"678_CR22","volume-title":"SEER Program Overview","author":"National Cancer Institute","year":"2010","unstructured":"National Cancer Institute. SEER Program Overview. 2010. \n                    https:\/\/seer.cancer.gov\/about\/factsheets\/SEER_Overview.pdf\n                    \n                  . Accessed 27 Jan 2017."},{"key":"678_CR23","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","volume":"295","author":"L Davies","year":"2006","unstructured":"Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164\u20137.","journal-title":"JAMA"},{"key":"678_CR24","volume-title":"A snapshot of thyroid cancer","author":"National Cancer Institute","year":"2014","unstructured":"National Cancer Institute. A snapshot of thyroid cancer. 2014. \n                    https:\/\/www.cancer.gov\/research\/progress\/snapshots\/thyroid\n                    \n                  . Accessed 27 Jan 2017."},{"key":"678_CR25","doi-asserted-by":"publisher","first-page":"e0121323","DOI":"10.1371\/journal.pone.0121323","volume":"10","author":"R Meza","year":"2015","unstructured":"Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. PLoS One. 2015;10:e0121323.","journal-title":"PLoS One"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-018-0678-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0678-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T19:05:14Z","timestamp":1565636714000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-018-0678-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["678"],"URL":"https:\/\/doi.org\/10.1186\/s12890-018-0678-5","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"15 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BC and MPN are employees of Novartis. MB and EC are employees of Partnership for Health Analytic Research, a health services research firm paid by Novartis to conduct this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"135"}}